EMR showing upside potential
Emerson is half way into the cycle with price target ranging from $93 to $96. I expect earnings to be good, but the recent indication for a hostile acquisition might overshadow the ER. I believe this will trend in a range until mid March when this could start its next leg up.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.